Helena Chang Chui, MDRaymond and Betty McCarron Professor ofNeurology and GerontologyChair, Department of NeurologyDirector, Alzheimer Disease Research Center Helena Chang Chui received her MD from The Johns Hopkins University School of Medicine and completed her residency in neurology and fellowship in behavioral neurology at the University of Iowa Hospitals and Clinics. She is the
Jae U. Jung, PhD Distinguished Professor Fletcher Jones Foundation Professor Hastings Foundation Professor Chair, Department of Molecular Microbiology and Immunology Director, USC Institute of Emerging Pathogens Dr. Jae U. Jung is an expert in the molecular biology of cancer-causing herpesviruses and emerging pathogens as they relate to cell biology, biochemistry and immunology. His
Neil Kaplowitz, MD Professor of Medicine; Chief, Division of Gastroenterology, Liver Diseases; USC Associates/Thomas H. Brem Chair in Medicine Dr. Neil Kaplowitz is the USC Associates-Brem Professor of Medicine, Garrie-Budnick Chair in Liver Disease and chief, division of gastrointestinal and liver disease in the Department of Medicine. He is also the director of
Christopher A. Haiman, ScDProfessor of Population and Public Health Sciences; AFLAC Chair in Cancer Research Christopher A. Haiman ScD is a professor in the Department of Population and Public Health Sciences and the USC Norris Comprehensive Cancer Center. He came to the Keck School of Medicine of USC in 2000 as a post-doctoral
Amy S. Lee, PhD Associate Director for Basic Research and Judy and Larry Freeman Cosmetic Chair, USC Norris Comprehensive Cancer Center; Professor of Biochemistry & Molecular Biology, Keck School of Medicine Dr. Lee’s major research focus is in the area of endoplasmic reticulum (ER) stress and, in particular, the ER chaperone proteins GRP78
David R. Hinton, MD, FARVO Professor of Pathology, Neurological Surgery, Ophthalmology; Associate Dean for Vision Science; Vice Chair for Research, Exam Committee Facilitator; Director, Dean's Research Scholars Program Dr. David Hinton’s research is focused on developing novel therapies for age-related macular degeneration (AMD) – the leading cause of irreversible blindness in the elderly.
